Smithers Avanza announced that its Bioanalytical Services Division has completed the second expansion of its bioanalytical laboratory in the last two years.
Smithers Avanza, a contract research organization (CRO) supporting the pharmaceutical and chemical industries, announced that Senior Toxicologist Caitlin Murphy, PhD has authored a white paper describing the company’s validation of its extended one-generation reproductive toxicity study (EOGRTS) capabilities.
Smithers Avanza has been granted a renewal of full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council on Accreditation. This renewal comes with no recommendations for improvement from AAALAC International.
Smithers Avanza has augmented its capabilities for pharmacokinetics (PK), immunogenicity, and biomarker testing through the addition of the Gyros Gyrolab™ xPS workstation.
Smithers Avanza announced that its Bioanalytical Services Division has Clinical Laboratory Improvement Amendments (CLIA) certification.
In a recent study of contract research organizations (CROs) around the world, the Pharma’s Almanac recognized Smithers Avanza among the top bioanalytical CROs. Pharma’s Almanac is published quarterly by independent researcher Nice Insight.
New Space & Increased Capacity Will Support Client Requests for Testing of Large Molecule Biotherapeutics